A product design company in Chester has been awarded funding to develop a voice-operated app to treat anxiety in young people.
Cadscan was awarded a contract through the Small Business Research Initiative for Healthcare to develop Phobot, providing interventions that support positive mental health.
Public Health England estimates that 10 per cent of children aged between five and 16 are likely to develop a clinically significant mental health disorder, one of which is anxiety. Cognitive behavioural therapy (CBT) is often recommended as a treatment option but the provision of therapy is often restricted due to demand.
Phobot aims to provide an easy way for young people dealing with anxiety to access treatment. Voice or text-operated, the app uses artificial intelligence and natural language understanding. This technology enables Phobot to interpret a user’s words and respond with a tailored treatment programme.
The funding has facilitated the first phase of development for Phobot, which is currently being tested on different platforms with a group of young people in partnership with the University of York.
Dr Simon Lewis, a clinical psychologist at Alder Hey Children’s NHS Foundation Trust, has been working with Cadscan on the development of Phobot. He said: “I’ve been working with the team to ensure that Phobot’s interactions with users are as close to real life therapy sessions as possible. We’ve done this by adhering to widely used CBT models of understanding and working with social anxiety as well as running mock sessions which are then transposed into adaptable scripts for Phobot.
“Phobot will help young people by using key elements from an evidence-based approach to social anxiety whilst being responsive, accessible and approachable.”
Innovation Agency Commercial Programme Manager Indi Singh said: “With a real desire to introduce new technologies to the NHS, Cadscan has been awarded the SBRI Healthcare contract for a creative and accessible solution to mental health needs among young people. I’m looking forward to seeing the development of Phobot and its application making a difference.”
Dr Alastair Buchanan, Managing Director of Cadscan, said: “Many young people find it hard to access treatment for anxiety. They can develop poor coping mechanisms, including avoidant behaviours or alcohol and drug use, which lead to further problems and limit their life chances. Phobot unobtrusively delivers effective, evidence-based support whenever they need it.”
SBRI Healthcare is an NHS England initiative, led by the Academic Health Science Network (AHSN), which aims to promote UK economic growth while addressing unmet health needs and enhancing the take-up of known best practice.
Photo: Cadscan Managing Director Dr Alastair Buchanan with Indi Singh of the Innovation Agency
News and blogs >
Welcome for 10-year NHS blueprint Read more
Health Innovation North West Coast has welcomed the Government’s Ten Year Plan for Health and its focus on innovation as a key factor in setting the NHS ‘back on its feet’.
Energy and optimism palpable at first AI in Healthcare Symposium Read more
The inaugural AI in Healthcare Symposium Conference was a platform for Cheshire and Merseyside healthcare professionals, academic partners and industry to shape a local AI ecosystem.
Getting the medication balance right Read more
Health Innovation North West Coast has helped set up a network of clinicians dedicated to tackling problems associated with the inappropriate prescribing of medicines.
Health innovations 'could boost economy by £278 billion' Read more
A new report reveals that innovations in healthcare could boost the UK’s growth by bringing in around £246 billion every year, while attracting a further £32billion in foreign direct investment (FDI).